- Home
- BANL vs CGTX Comparison
BANL vs CGTX Comparison
Compare BANL & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- CGTX
- Stock Information
- Founded
- BANL 2015
- CGTX 2007
- Country
- BANL Malaysia
- CGTX United States
- Employees
- BANL N/A
- CGTX N/A
- Industry
- BANL Oil Refining/Marketing
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- BANL Energy
- CGTX Health Care
- Exchange
- BANL Nasdaq
- CGTX Nasdaq
- Market Cap
- BANL 31.5M
- CGTX 26.8M
- IPO Year
- BANL 2023
- CGTX 2021
- Fundamental
- Price
- BANL $1.08
- CGTX $0.35
- Analyst Decision
- BANL
- CGTX Strong Buy
- Analyst Count
- BANL 0
- CGTX 5
- Target Price
- BANL N/A
- CGTX $7.13
- AVG Volume (30 Days)
- BANL 46.5K
- CGTX 626.3K
- Earning Date
- BANL 04-16-2025
- CGTX 05-06-2025
- Dividend Yield
- BANL N/A
- CGTX N/A
- EPS Growth
- BANL N/A
- CGTX N/A
- EPS
- BANL N/A
- CGTX N/A
- Revenue
- BANL $521,173,543.00
- CGTX N/A
- Revenue This Year
- BANL N/A
- CGTX N/A
- Revenue Next Year
- BANL N/A
- CGTX N/A
- P/E Ratio
- BANL N/A
- CGTX N/A
- Revenue Growth
- BANL 24.34
- CGTX N/A
- 52 Week Low
- BANL $0.55
- CGTX $0.31
- 52 Week High
- BANL $1.35
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- BANL 53.18
- CGTX 38.10
- Support Level
- BANL $0.80
- CGTX $0.31
- Resistance Level
- BANL $1.16
- CGTX $0.36
- Average True Range (ATR)
- BANL 0.10
- CGTX 0.04
- MACD
- BANL 0.01
- CGTX -0.00
- Stochastic Oscillator
- BANL 77.72
- CGTX 24.56
Stock Price Comparison Chart: BANL vs CGTX
About BANL CBL International Limited
CBL International Ltd is a company that provides a complete range of marine fuel logistics services. It sources the highest quality marine fuel from its trusted suppliers and ensures timely delivery to its customers. The company's expertise lies in providing a seamless and efficient one-stop solution for vessel refueling needs, making it a reliable partner for shipping companies. CBL International Ltd has a strong presence in China, Hong Kong, and Malaysia.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.